AnalystsJustin KimJustin Kim's Stock Forecasts
AnalystsJustin Kim
Sectors:
Industries:
Analyst Ranking
Top 23%
#1039 out of 4566 analysts
Average Return
+4.4%
Win Rate
47%14 out of 30
Risk vs Reward
Poor
Good
Justin Kim's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Provention Bio IncPRVB | +209.16% | $8.08 | $24.98 | 2022-11-18 - 2023-04-27 | Buy |
Chinook Therapeutics IncKDNY | +85.11% | $21.82 | $40.39 | 2023-02-28 - 2023-08-10 | Buy |
Pharvaris NvPHVS | +81.98% | $10.99 | $20.00 | 2022-08-23 - 2023-08-22 | Buy |
Chinook Therapeutics IncKDNY | +76.99% | $22.82 | $40.39 | 2023-02-21 - 2023-08-10 | Buy |
Cytokinetics IncCYTK | +75.50% | $37.23 | $65.34 | 2023-05-16 - 2024-04-26 | Buy |
Justin Kim Analyst Color
Get additional color on Justin Kim's coverage of popular stocks
Justin Kim's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cytokinetics IncCYTK | 4 | Buy | $107.00 | +63.76% | Reiterates | 2 months ago |
Immunocore Holdings PLCIMCR | 5 | Buy | $87.00 | +48.82% | Reiterates | 2 months ago |
Apellis Pharmaceuticals IncAPLS | 4 | Buy | $79.00 | +58.44% | Maintains | 3 months ago |
Vera Therapeutics IncVERA | 1 | Buy | $26.00 | -34.43% | Initiates Coverage On | 3 months ago |
Zura Bio LtdZURA | 1 | Buy | $17.00 | +285.49% | Initiates Coverage On | 8 months ago |
Aldeyra Therapeutics IncALDX | 1 | Buy | $14.00 | +256.23% | Reiterates | 9 months ago |
Chinook Therapeutics IncKDNY | 2 | Buy | $34.00 | N/A | Maintains | a year ago |
Provention Bio IncPRVB | 3 | Buy | $18.00 | N/A | Maintains | a year ago |
Aurinia Pharmaceuticals IncAUPH | 5 | Hold | N/A | N/A | Downgrades | a year ago |
Pharvaris NvPHVS | 2 | Buy | $22.00 | N/A | Maintains | 2 years ago |
Biocryst Pharmaceuticals IncBCRX | 4 | Hold | N/A | N/A | Downgrades | 2 years ago |
Ionis Pharmaceuticals IncIONS | 1 | Buy | $59.00 | N/A | Assumes | 2 years ago |
Elicio Therapeutics IncELTX | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.